SAM
Silvercrest Asset Management’s Moderna MRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,880
| Closed | -$223K | – | 820 |
|
2024
Q2 | $223K | Sell |
1,880
-1,240
| -40% | -$147K | ﹤0.01% | 855 |
|
2024
Q1 | $332K | Sell |
3,120
-4
| -0.1% | -$426 | ﹤0.01% | 787 |
|
2023
Q4 | $311K | Buy |
3,124
+840
| +37% | +$83.5K | ﹤0.01% | 744 |
|
2023
Q3 | $236K | Buy |
+2,284
| New | +$236K | ﹤0.01% | 778 |
|
2022
Q1 | – | Sell |
-1,230
| Closed | -$312K | – | 869 |
|
2021
Q4 | $312K | Buy |
1,230
+30
| +3% | +$7.61K | ﹤0.01% | 735 |
|
2021
Q3 | $462K | Hold |
1,200
| – | – | ﹤0.01% | 689 |
|
2021
Q2 | $282K | Buy |
+1,200
| New | +$282K | ﹤0.01% | 764 |
|